Drug Eluting Balloon for Peripheral Artery Disease Market was valued at USD 0.45 Billion in 2022 and is projected to reach USD 1.1 Billion by 2030, growing at a CAGR of 15.1% from 2024 to 2030.
However, the market outlook from 2023 to 2033 presents a slightly different picture. Although demand for DEBs remains strong, there are emerging trends and challenges that will shape the market in the coming decade. On one hand, the market is expected to experience continued growth driven by innovations in balloon technology, improvements in drug formulations, and the expanding understanding of PAD treatment. Newer balloon designs that allow for more precise drug delivery and longer-lasting results will likely continue to capture a significant share of the market. Additionally, non-invasive diagnostic tools are expected to aid in earlier PAD detection, driving earlier treatment interventions and the demand for DEBs.
On the other hand, challenges such as the high cost of DEB treatments and the competition from alternative therapies may impact the market growth. With healthcare systems under pressure to reduce costs, the adoption of DEBs may face resistance in some regions. However, the market will likely see innovations aimed at reducing treatment costs and improving patient accessibility to these advanced therapies.
Get an In-Depth Research Analysis of the Global Drug Eluting Balloon for Peripheral Artery Disease Market Size And Forecast [2025-2032]
The drug-eluting balloon (DEB) market for Peripheral Artery Disease (PAD) has undergone notable transformations between 2018 and 2022, marked by advancements in medical technologies, growing demand for minimally invasive procedures, and rising awareness of PAD's prevalence. In this period, the use of DEBs, designed to treat blockages in peripheral arteries, gained significant traction due to their ability to reduce restenosis rates compared to traditional angioplasty balloons. This period witnessed an increase in the number of patients seeking alternative treatments to open surgeries, highlighting the shift toward more effective and less invasive treatments.
During this period, several key players in the market introduced innovative DEBs, which further contributed to the growth of the market. The introduction of more advanced drug-eluting technologies improved the success rates of angioplasty procedures, offering patients better long-term outcomes. The overall demand for DEBs rose due to factors like the increasing prevalence of risk factors such as diabetes and hypertension, as well as the aging population, all contributing to the rising number of PAD cases globally.
Cook Group
BD
Medtronic
Bayer
Opto Circuits
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Drug Eluting Balloon for Peripheral Artery Disease Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Drug Eluting Balloon for Peripheral Artery Disease Market
Hospitals
Ambulatory Surgery Centers
Catheterization Laboratories
Others
Based on Types the Market is categorized into Below types that held the largest Drug Eluting Balloon for Peripheral Artery Disease market share In 2023.
3μg/ mm2
2μg/ mm2
Others
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Drug Eluting Balloon for Peripheral Artery Disease Market Research Analysis
1. Introduction of the Global Drug Eluting Balloon for Peripheral Artery Disease Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Drug Eluting Balloon for Peripheral Artery Disease Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Drug Eluting Balloon for Peripheral Artery Disease Market, By Type
6. Global Drug Eluting Balloon for Peripheral Artery Disease Market, By Application
7. Global Drug Eluting Balloon for Peripheral Artery Disease Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Drug Eluting Balloon for Peripheral Artery Disease Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/